Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company (KFSHI), posted on X:
“CML Treatment Algorithm.
Guided by NCCN and ELN.
- Assess patient(comorbidities, heart, lungs, GI).
- Risk stratification(Sokal, Hasford, EUTOS).
Treatment
- Low risk: Imatinib
- Intermediate/high: 2nd-gen TKIs
Monitor(bcr-abl PCR)
Treatment-free remission.”
